The role of inflammation in CNS injury and disease
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
For many years, the central nervous system (CNS) was considered to be ‘immune privileged’, neither susceptible to nor contributing to inflammation. It is now appreciated that the CNS does exhibit features of inflammation, and in response to injury, infection or disease, resident CNS cells generate inflammatory mediators, including proinflammatory cytokines, prostaglandins, free radicals and complement, which in turn induce chemokines and adhesion molecules, recruit immune cells, and activate glial cells. Much of the key evidence demonstrating that inflammation and inflammatory mediators contribute to acute, chronic and psychiatric CNS disorders is summarised in this review. However, inflammatory mediators may have dual roles, with detrimental acute effects but beneficial effects in long‐term repair and recovery, leading to complications in their application as novel therapies. These may be avoided in acute diseases in which treatment administration might be relatively short‐term. Targeting interleukin (IL)‐1 is a promising novel therapy for stroke and traumatic brain injury, the naturally occurring antagonist (IL‐1ra) being well tolerated by rheumatoid arthritis patients. Chronic disorders represent a greater therapeutic challenge, a problem highlighted in Alzheimer's disease (AD); significant data suggested that anti‐inflammatory agents might reduce the probability of developing AD, or slow its progression, but prospective clinical trials of nonsteroidal anti‐inflammatory drugs or cyclooxygenase inhibitors have been disappointing. The complex interplay between inflammatory mediators, ageing, genetic background, and environmental factors may ultimately regulate the outcome of acute CNS injury and progression of chronic neurodegeneration, and be critical for development of effective therapies for CNS diseases. British Journal of Pharmacology (2006) 147, S232–S240. doi:10.1038/sj.bjp.0706400
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As various neurological and psychiatric diseases have been associated with neuroinflammation in some post-mortem studies,183, 184, 185”
From Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: a systematic review (2018) · cites this paper as [183]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Stroke is caused by ischaemia, leading to inflammation [900] and to the formation of ROS and other damaging free radicals [901] in the brain”
The cited source says what the claim attributes to it.
In the citing paper
“These processes induce adhesion molecules and, in order, mobilize immune and glial cells in a parallel and synergistic way (94, 126 -128).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [127]
In the citing paper
“Thus, although this is not the focus of the present more physiologically based review, we recognise that many of relationships between ROSs and oxidative stress and overt progressive diseases may be mediated via the inflammatory signalling pathways involved in 'innate immunity' [900,1991-1993].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Reactive Astrocytes Protect Tissue and Preserve Function after Spinal Cord Injury
Faulkner, J. R., Herrmann, J. E., Woo, M. J., Tansey, K. E., Doan, N. B., & Sofroniew, M. V. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3547-03.2004 · Cited by 1,598 · cited 1×
“…for repair and recovery, but in fact this increases neuronal loss from the injury site and inhibits repair of the BBB and axonal remyelination (Faulkner et al., 2004), partly because astrocytes produce neurotrophic factors such as nerve growth factor and brain-derived growth factor that are…”
BackgroundMcGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367 · cited 1×
“Although other epidemiological studies also suggest a beneficial role for antiinflammatory agents in AD (McGeer et al., 1996), the general view from prospective trials of nonsteroidal inflammatory drugs (NSAIDs) is that they are disappointingly variable.”
BackgroundTNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,017
Interleukin 1 in the brain: biology, pathology and therapeutic target
Rothwell, N. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01661-1 · Cited by 671 · cited 3×
“IL-1 was discovered as an important endogenous pyrogen, and is now recognised as the ‘prototypic inflammatory cytokine’ (reviewed by Rothwell & Luheshi, 2000).”
BackgroundInfluentialSelf-citationPerry, V. H. (2004) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2004.01.004 · Cited by 560 · cited 2×
“…metalloproteinase and iNOS activities, and breakdown of the BBB. Complications of its use however include inhibition of remyelination in MS models, and observations that microglial activation may be associated with anti-inflammatory cytokine expression rather than proinflammatory (Perry, 2004).”
BackgroundInflammation and the Degenerative Diseases of Aging
McGEER, P. L., & McGEER, E. G. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.007 · Cited by 518 · cited 1×
“The complement cascade is activated, and mRNAs for complement proteins are upregulated in PD (and AD) to a greater extent than in peripheral inflammatory diseases such as rheumatoid arthritis (reviewed by McGeer & McGeer, 2004).”
BackgroundScherbel, U., Raghupathi, R., Nakamura, M., Saatman, K. E., Trojanowski, J. Q., Neugebauer, E., Marino, M. W., & McIntosh, T. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8721 · Cited by 415 · cited 1×
“…injury, the TNFa knockout mice show less behavioural impairment than the wild-type controls, but while the wild-type mice recovered in the weeks following injury, the knockout mice did not, remaining significantly impaired both in terms of histological damage and behaviour (Scherbel et al., 1999).”
BackgroundNew Insights into the Biology of the Acute Phase Response
Suffredini, A. F., Fantuzzi, G., Badolato, R., Oppenheim, J. J., & O'Grady, N. P. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020563913045 · Cited by 391 · cited 1×
“This represents another host defence mechanism which can limit proliferation of invading pathogens (Suffredini et al., 1999).”
BackgroundVezzani, A., Moneta, D., Richichi, C., Aliprandi, M., Burrows, S. J., Ravizza, T., Perego, C., & De Simoni, M. G. (2002) · Epilepsia · doi:10.1046/j.1528-1157.43.s.5.14.x · Cited by 386 · cited 1×
“Exogenous IL-1b enhances chemically induced seizures in rats and IL-1ra inhibits motor seizures and delays their onset (see Vezzani et al., 2002).”
Background
Cited by
Items 401–500 of 1,000
Hajam, T. A., & H, S. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110237 · Cited by 59
ynthesis, Anti-Inflammatory and Antioxidant Activities of Novel 3H-Thiazolo[4,5-b]Pyridines
Chaban, T. I., Ogurtsov, V. V., Matiychuk, V. S., Chaban, I. G., Demchuk, I., & Nektegayev, I. A. (2019) · Acta chimica slovenica · doi:10.17344/acsi.2018.4570 · Cited by 59
Joya, X., García‐Algar, Ó., Salat‐Batlle, J., Pujades, C., & Vall, O. (2014) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.23290 · Cited by 59
Hu, M. H., Zheng, Q. F., Jia, X. Z., Li, Y., Dong, Y. C., Wang, C. Y., Lin, Q. Y., Zhang, F. Y., Zhao, R. B., Xu, H. W., et al. (2014) · Clinical and Experimental Immunology · doi:10.1111/cei.12219 · Cited by 57
Pietro, V. D., Amin, D., Pernagallo, S., Lazzarino, G., Tavazzi, B., Vagnozzi, R., Pringle, A. K., & Belli, A. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2009.1095 · Cited by 59
“IL-1 is one of the most widely studied proinflammatory cytokines, and it has been implicated in a number of neurodegenerative disorders, both acute and chronic (Allan et al., 2005; Lucas et al., 2006).”
Neuron–glia signaling: Implications for astrocyte differentiation and synapse formation
Stipursky, J., Romão, L. F., Tortelli, V., Moura‐Neto, V., & Gomes, F. C. A. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.04.005 · Cited by 59
“…here, activation of astrocytes generates a diverse range of downstreammediators, including cytokines (Balasingamet al., 1994; John et al., 2003; Lucas et al., 2006; Kim et al., 2010), NO and ROS (Rao et al., 2003; Hensley et al., 2006;Wang et al., 2011), and loss of basic functions important…”
BackgroundLichen-derived compounds show potential for central nervous system therapeutics
Reddy, R. G., Veeraval, L., Maitra, S., Chollet‐Krugler, M., Tomasi, S., Dévéhat, F. L., Boustié, J., & Chakravarty, S. (2016) · Phytomedicine · doi:10.1016/j.phymed.2016.08.010 · Cited by 59
Song, Y., Lu, M., Yuan, H., Chen, T., & Han, X. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8789 · Cited by 59
“As the major immune effector cells of the brain, microglia continuously monitor the surrounding environment and provide an immunosurveillance function for brain damage (26).”
BackgroundInfluentialStahel, P. F., Smith, W. R., Bruchis, J., & Rabb, C. H. (2008) · PPAR Research · doi:10.1155/2008/538141 · Cited by 52
“Since PPARs inhibit proinflammatory gene transcription by attenuating NF-κB signaling [43–45], the potent PPAR-mediated neuroprotective effects may be dependent on inhibition of NF-κB-dependent proinflammatory cytokines released in the injured brain, such as TNF, interleukin (IL)-1, IL-8, IL12, and IL-18 [57–61].”
Kumar, R. G., Rubin, J. E., Berger, R. P., Kochanek, P. M., & Wagner, A. K. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.12.008 · Cited by 58
“Post-traumatic inflammation is a complex component of the secondary injury cascade that has been well-documented in both humans and experimental models (Jeong et al. , 2013; Lucas et al. , 2006; Woodcock and Morganti-Kossmann, 2013).”
Oh, N. S., Joung, J. Y., Lee, J. Y., Song, J. G., Oh, S., Kim, Y., Kim, H. W., & Kim, S. H. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1756690 · Cited by 58
Bahia, M. S., & Silakari, O. (2010) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2010.00950.x · Cited by 58
Teng, S. X., & Molina, P. E. (2013) · Journal of Neurotrauma · doi:10.1089/neu.2013.3093 · Cited by 58
Lu, X. M., Chen, R., Yao, C., Wei, H. H., Yang, X., Liao, Z., Dave, J. R., & Tortella, F. C. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008.0629 · Cited by 58
Zhao, L., Jiang, B., Wu, X., Cao, D., & Gao, Y. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12502 · Cited by 58
“…role in the pathogenesis of many neurological disorders, including neurodegenerative diseases, ischemic stroke, psychiatric illness and chronic pain (Minghetti, 2005; Lucas et al., 2006; Savarin-Vuaillat & Ransohoff, 2007; White & Wilson, 2008; Mirabelli-Badenier et al., 2011; Najjar et al., 2013).”
BackgroundDual impact of neuroinflammation on cognitive and motor impairments in Alzheimer's disease
Fakorede, S., Lateef, O. M., Garuba, W. A., Akosile, P. O., Okon, D. A., & Aborode, A. T. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251341870 · Cited by 57
Stroke induced brain changes: Implications for stem cell transplantation
Jabłońska, A., & Łukomska, B. (2011) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2011-1824 · Cited by 57
“Also the other factors released by microglia i.e. brain-derived neurotrophic factor (BDNF), insulin-like growth factor I (IGF-I) have been shown to be protective contributing to neurogenesis (Lucas et al. 2006, Ekdahl et al. 2009).”
BackgroundMazumder, A. G., Patial, V., & Singh, D. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.09.020 · Cited by 57
Takenouchi, T., Iwamaru, Y., Sugama, S., Sato, M., Hashimoto, M., & Kitani, H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.7827 · Cited by 57
“, IL-1 , IL-6, and TNF- , secreted from microglia in brains likely correlates with the progression of neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease (4, 5).”
BackgroundNishimura, Y., Moriyama, M., Kawabe, K., Satoh, H., Takano, K., Azuma, Y.-T., & Nakamura, Y. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2587-7 · Cited by 56
Giuliano, C., Cerri, S., & Blandini, F. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.290879 · Cited by 56
“In the central nervous system, after an injury, a sequence of events take place including the production of inflammatory mediators, the recruitment of immune cells into the parenchyma and the activation of glial cells (microglia and astrocytes): all these phenomena are referred to as neuroinflammation (Lucas et al., 2…”
Jia, Y., Zhang, D., Yin, H., Li, H., Du, J., & Bao, H. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03303-3 · Cited by 56
“Stimulating of BV2 microglial cells by LPS lead to the production of pro-inflammatory cytokines, such as IL-1β, IL-6 and TNF-α, which have been confirmed that could cause neural cell damage, initiate and amplify the inflammatory response, and lead to the development of neurodegenerative diseases [29]; Therefore, the s…”
BackgroundWilliams, W. M., Castellani, R. J., Weinberg, A., Perry, G. L., & Smith, M. A. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/905785 · Cited by 56
“Studies in vivo indicate that chronic activation of the innate immune response can induce neuronal injury [120–122], perhaps through activation of the inflammasome complex [123].”
BackgroundChan, J. L., Reeves, T. M., & Phillips, L. L. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.08.015 · Cited by 54
“Two mechanisms controlling reinnervation are acute inflammation (Correale and Villa, 2004; Lucas et al., 2006 ), and activation of extracellular matrix (ECM) molecules surrounding synapses (Venstrom and Reichardt, 1993; Dityatev and Schachner, 2003).”
BackgroundAnti-inflammatory activity of total flavonoids from seeds of Camellia oleifera Abel
Liu, X., Jia, L.-Y., Gao, Y., Li, B., & Tu, Y. (2014) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmu071 · Cited by 56
“Persistent inflammation is closely associated with many chronic diseases, such as cancer, arthritis, osteoporosis, asthma, Alzheimer’s disease, obesity, diabetes, and cardiovascular disease [1].”
BackgroundMuneer, P. M. A., Long, M., Conte, A. A., Santhakumar, V., & Pfister, B. J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9949-4 · Cited by 56
Hydrogen sulfide suppresses homocysteine-induced glial activation and inflammatory response
Kumar, M., & Sandhir, R. (2019) · Nitric Oxide · doi:10.1016/j.niox.2019.05.008 · Cited by 56
Jisha, N., Vysakh, A., Vijeesh, V., & Latha, M. S. (2019) · Pathophysiology · doi:10.1016/j.pathophys.2019.08.002 · Cited by 57
Lead Optimization Studies of Cinnamic Amide EP2 Antagonists
Ganesh, T., Jiang, J., Yang, M.-S., & Dingledine, R. J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5000672 · Cited by 55
Beneficial effects of sodium or ethyl pyruvate after traumatic brain injury in the rat
Moro, N., & Sutton, R. L. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.07.013 · Cited by 55
Chao, W., Kuo, Y., Hsieh, S.-L., & Lin, B. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep120 · Cited by 55
“Mechanism of action of MIP2 on inflammation in brain is less documented compared with those of cytokines and chemokines, such as TNF-α, IL-1β, MCP-1 and MIP-1, though they all increase in both the periphery and in the brain when LPS is administered peripherally [33, 34].”
BackgroundAbusive Head Trauma: A Review of the Evidence Base
Greeley, C. S. (2015) · American Journal of Roentgenology · doi:10.2214/ajr.14.14191 · Cited by 55
“In addition, the presence of SDH is associated with a clinically significant inflammatory response [78].”
BackgroundKadhim, H., Deltenre, P., Martin, J.-J., & Sébire, G. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2015.11.022 · Cited by 54
Triblock Conjugates: Identification of a Highly Potent Antiinflammatory Agent
Singh, P., Kaur, J., Singh, G., & Bhatti, R. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00952 · Cited by 54
Koopmans, G. C., Deumens, R., Buss, A., Geoghegan, L., Myint, A.-M., Honig, W. M. M., Kern, N., Joosten, E. A. J., Noth, J., & Brook, G. A. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.01.005 · Cited by 54
The contribution of astrocytes to Alzheimer's disease
Birch, A. M. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140171 · Cited by 47
Emerging drugs for spinal cord injury
Baptiste, D. C., & Fehlings, M. G. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.13.1.63 · Cited by 54
Cerebral and Hepatic Inflammatory Response after Neonatal Hypoxia-Ischemia in Newborn Rats
Bonestroo, H. J. C., Nijboer, C. H. A., van Velthoven, C. T. J., Kavelaars, A., Hack, C. E., van Bel, F., & Heijnen, C. J. (2013) · Developmental Neuroscience · doi:10.1159/000346685 · Cited by 54
The Role of the Neuroprotective Factor Npas4 in Cerebral Ischemia
Choy, F. C., Klarić, T., Koblar, S. A., & Lewis, M. D. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226144 · Cited by 54
“In ischemic brain injury, interleukin (IL)-6 and tumor necrosis factor alpha (TNF-α) are largely thought to act as pro-inflammatory cytokines which exacerbate brain damage and are involved in the initiation of early inflammation [96].”
BackgroundAnti-Inflammatory Activity of Iridoid and Catechol Derivatives fromEucommia ulmoidesOliver
Luo, D., Or, T. C. T., Yang, C. L.-H., & Lau, A. S. Y. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5001205 · Cited by 54
Singh, P., Kaur, S., Sharma, A., Kaur, G., & Bhatti, R. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.09.003 · Cited by 54
Antiinflammatory Potential of Medicinal Plants: A Source for Therapeutic Secondary Metabolites
Bernstein, N., Akram, M., Daniyal, M., Koltai, H., Fridlender, M., & Gorelick, J. (2018) · Advances in agronomy · doi:10.1016/bs.agron.2018.02.003 · Cited by 55
Gonçalves, L. V., Herlinger, A. L., Ferreira, T. A. A., Coitinho, J. B., Pires, R. G. W., & Martins-Silva, C. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.04.023 · Cited by 53
Civiletti, F., Assenzio, B., Mazzeo, A. T., Medica, D., Giaretta, F., Deambrosis, I., Fanelli, V., Ranieri, V. M., Cantaluppi, V., & Mascia, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-42147-4 · Cited by 54
Epileptogenesis due to glia-mediated synaptic scaling
Savin, C., Triesch, J., & Meyer-Hermann, M. (2009) · Journal of The Royal Society Interface · doi:10.1098/rsif.2008.0387 · Cited by 50
“Keywords: homeostasis; synaptic scaling; neuron–glia interaction; neuro-immune interaction; epilepsy”
BackgroundAïd, S., & Bosetti, F. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.02.015 · Cited by 54
“Some authors have raised the possibility that inflammation may occur during normal aging and increase the vulnerability to neurodegenerative disorders such as Alzheimer’s disease (AD) [7,20,26].”
BackgroundNeuroinflammation and hypothalamo-pituitary dysfunction: focus of traumatic brain injury
Mele, C., Pingue, V., Caputo, M., Zavattaro, M., Pagano, L., Prodam, F., Nardone, A., Aimaretti, G., & Marzullo, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052686 · Cited by 53
Curcumin Inhibits LPS-Induced CCL2 Expression via JNK Pathway in C6 Rat Astrocytoma Cells
Zhang, Z., Zhao, L., Cao, D., Zhang, X., Gao, Y., & Xia, C. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9816-4 · Cited by 53
Hwang, S., Choi, Y. G., Jeong, M., Hong, Y., Lee, J.-H., & Lim, S. (2009) · Gene · doi:10.1016/j.gene.2009.04.024 · Cited by 53
“The actions of IL-1 in the CNS are diverse and include induction of growth factors, reduction of glutamate release, enhanced gamma-aminobutyric acid (GABA) effects, modulation of neuronal responses to N-methyl-Daspartic acid (NMDA) and glycine, and increased activation of iNOS (Lucas et al., 2006).”
BackgroundInfluentialJohann, S., Kampmann, E., Denecke, B., Arnold, S., Kipp, M., Mey, J., & Beyer, C. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-9028-4 · Cited by 53
“Acute inflammation is typically associated with ischemia or spinal cord trauma ( Lucas et al. 2006 ).”
BackgroundZhao, B., Wang, J., Liu, L., Li, X., Liu, S., Xia, Q., & Shi, J. (2016) · Scientific Reports · doi:10.1038/srep27028 · Cited by 53
“This process is called persistent neuro-inflammation, or reactive gliosis, which develops in many acute and chronic neurological conditions, such as stroke, Parkinson’s and, Alzheimer’s disease, as well as motorneuron and prion diseases 57–59 .”
Wang, D., Duan, H., Feng, J., Xiang, J., Feng, L., Liu, D., Chen, X., Jing, L., Liu, Z., Zhang, D., et al. (2019) · Theranostics · doi:10.7150/thno.37142 · Cited by 54
“Under CNS inflammation, the tight junctions between brain ECs disappear, and the attached pericytes and astrocytes fall off [7].”
BackgroundKushairi, N., Tarmizi, N. A. K. A., Phan, C., Macreadie, I. G., Sabaratnam, V., Naidu, M. K., & David, P. R. (2020) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.07.029 · Cited by 53
Liu, K., Cai, G., Zhuang, Z., Pei, S., Xu, S., Wang, Y., Wang, H., Wang, X., Cui, C., Sun, M., et al. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s289914 · Cited by 52
LilrB3 is a putative cell surface receptor of APOE4
Zhou, J., Wang, Y., Huang, G., Yang, M., Zhu, Y., Jin, C., Jing, D., Ji, K., & Shi, Y. (2023) · Cell Research · doi:10.1038/s41422-022-00759-y · Cited by 52
Anti-inflammatory activity of constituents from Glechoma hederacea var. longituba
Kim, J.-P., Song, S., Lee, I. S., Kim, Y. H., Yoo, I., Ryoo, I., & Bae, K. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.02.002 · Cited by 52
Neuroprotective Effect of trans-Cinnamaldehyde on the 6-Hydroxydopamine-Induced Dopaminergic Injury
Pyo, J.-H., Jeong, Y.-K., Yeo, S., Lee, J.-H., Jeong, M., Kim, S., Choi, Y., & Lim, S. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00537 · Cited by 52
Neurobiological aspects of Alzheimer's disease
Chopra, K., Misra, S., & Kuhad, A. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.557363 · Cited by 52
“Several amyloid peptides and APP can act as potent glial activators [75], and disruption of the APP gene and its proteolytic products delay and decrease microglial activation [76].”
BackgroundPost-traumatic Stress Disorder: Focus on Neuroinflammation
Li, J., Tong, L., Schock, B. C., & Ji, L.-L. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03320-z · Cited by 51
“1 3 aggravate neurodegeneration of the central nervous system (CNS) while also facilitating the repair and recovery of injured neurons [21].”
BackgroundStructure and Dynamics of ASC2, a Pyrin Domain-only Protein That Regulates Inflammatory Signaling
Natarajan, A., Ghose, R., & Hill, J. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605458200 · Cited by 51
Eleftheriadis, N., Poelman, H., Leus, N. G. J., Honrath, B., Neochoritis, C. G., Dolga, A. M., Dömling, A. S. S., & Dekker, F. J. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.07.010 · Cited by 51
“[1–4] In addition, elevated levels of IL-1, IL-6 and TNFα have been identified in brain tissue of patients with Alzheimer’s (AD)[1,5,6] and Parkinson’s (PD)[1,7] disease.”
BackgroundZhang, T., Li, C., Cao, L.-T., Bai, X., Zhao, D., & Sun, S. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10236-0 · Cited by 51
Ahmad, R., Khan, A., Rehman, I. U., Lee, H. J., Khan, I., & Kim, M. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116086 · Cited by 51
“TBI initiates a chronic biochemical process leading to microglia/astrocytes activation and neuritis that may contribute to later neuronal dysfunction [25,35,36].”
BackgroundFolkersma, H., Brevé, J. J. P., Tilders, F. J. H., Cherian, L., Robertson, C. S., & Vandertop, W. P. (2008) · Acta Neurochirurgica · doi:10.1007/s00701-008-0151-y · Cited by 47
Weiser, T. W. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1527-3458.2007.00032.x · Cited by 51
“In some of these disorders antiinflammatory drugs are used as standard therapy (for review, see Zipp and Aktas 2006; Lucas et al. 2006).”
BackgroundKwon, S., Ma, S.-X., Hwang, J. Y., Ko, Y., Seo, J.-Y., Lee, B. R., Lee, S., & Jang, C. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2015.150 · Cited by 50
“These enzymes are believed to contribute to the pathogenesis of AD, PD, and stroke, as assessed by postmortem examinations of various patients (Lucas et al., 2006; Heneka and O'Banion, 2007; Amor et al., 2010).”
BackgroundAnti-inflammatory properties of Honokiol in activated primary microglia and astrocytes
Rickert, U., Cossais, F., Heimke, M., Arnold, P., Preuße-Prange, A., Wilms, H., & Lucius, R. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.07.013 · Cited by 50
(+)-JQ1 attenuated LPS-induced microglial inflammation via MAPK/NFκB signaling
Wang, H., Huang, W., Liang, M., Shi, Y., Zhang, C., Li, Q., Liu, M., Shou, Y., Yin, H., Zhu, X., et al. (2018) · Cell & Bioscience · doi:10.1186/s13578-018-0258-7 · Cited by 50
Long noncoding RNA SNHG4: a novel target in human diseases
Chu, Q., Gu, X., Zheng, Q., Guo, Z., Shan, D., Wang, J., & Zhu, H. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02292-1 · Cited by 50
Brüning, C. A., Prigol, M., Luchese, C., Jessé, C. R., Duarte, M. M. M. F., Roman, S. S., & Nogueira, C. W. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0853-7 · Cited by 50
“molecules including NO, ROS and prostanoids [44].”
Patzer, A., Zhao, Y., Stöck, I., Gohlke, P., Herdegen, T., & Čulman, J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06478.x · Cited by 50
“after cerebral ischaemia, in the initiation and promotion of inflammation cascades and the development of secondary brain damage (Sharma & Kumar, 1998; Dirnagl et al., 1999; Allan & Rothwell, 2003; Lucas et al., 2006).”
BackgroundTeng, S. X., Katz, P. S., Maxi, J. K., Mayeux, J. P., Gilpin, N. W., & Molina, P. E. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.11.006 · Cited by 50
Fakhfouri, G., Mousavizadeh, K., Mehr, S. E., Dehpour, A. R., Zirak, M. R., Ghia, J., & Rahimian, R. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8957-5 · Cited by 50
Maeda, T., Kiguchi, N., Fukazawa, Y., Yamamoto, A., Ozaki, M., & Kishioka, S. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301213 · Cited by 50
“After acute brain injury or infection, there is a complex inflammatory response that involves activation of microglia and astrocytes and increased production of inflammatory chemical mediators (Lucas et al, 2006).”
BackgroundNeuroimmunometabolism: A New Pathological Nexus Underlying Neurodegenerative Disorders
Mitra, S., Banik, A., Saurabh, S., Maulik, M., & Khatri, S. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0998-21.2022 · Cited by 50
“The triggering, activation, and persistence of inflammation, mediated by glial cells, are influenced by environmental factors and genetic predispositions (Lucas et al., 2006).”
Jin, Z., Dong, J., Wang, Y., & Liu, Y. (2023) · European journal of medical research · doi:10.1186/s40001-023-01439-2 · Cited by 49
“The occurrence and development of CNS diseases are usually accompanied by inflammation [15].”
BackgroundVojnits, K., de León, A., Rathore, H., Liao, S., Zhao, M., Gibon, J., & Pakpour, S. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.134017 · Cited by 49
Grippo, A. J., & Scotti, M. L. (2013) · Modern trends in psychiatry · doi:10.1159/000343965 · Cited by 49
Safe Treatment of Seizures in the Setting of HIV/AIDS
Siddiqi, O. K., & Birbeck, G. L. (2013) · Current Treatment Options in Neurology · doi:10.1007/s11940-013-0237-6 · Cited by 49
Xia, Y., Kong, L., Yao, Y., Jiao, Y., Song, J., Tao, Z., You, Z., & Yang, J. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0373-x · Cited by 45
“modulate neuronal survival and death at the site of injury [14–17], while activated microglia release cytokines, reactive oxygen species, and other cytotoxic factors, further inducing neuronal death [16–18].”
BackgroundC-Reactive Protein Correlates with Negative Symptoms in Patients with Schizophrenia
Boozalis, T., Teixeira, A. L., Cho, R. Y.-J., & Okusaga, O. O. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00360 · Cited by 49
Zhai, P., Xu, L., Yang, J., Jiang, Z., Zhao, G.-W., Sun, L., Wang, G., & Li, X. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.02.026 · Cited by 49
“…nuclear c brain injury; TNF-a, tumour ride. x: þ86 513 85051646. work. enan University, 357 Ximen a. 106 107 108 109 110 111 112 113 114 115 116 et al., Reduction of inflammat ology (2015), http://dx.doi.or contribute to secondary brain injury (Morganti-Kossmann et al., 2002; Lucas et al., 2006).”
Chronic Hyperhomocysteinemia Increases Inflammatory Markers in Hippocampus and Serum of Rats
da Cunha, A. A., Ferreira, A. G. K., Loureiro, S. O., da Cunha, M. J., Schmitz, F., Netto, C. A., & Wyse, Â. T. D. S. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0769-2 · Cited by 50
“Brain inflammation is characterized by activation of microglia, which releasing a number of factors that modulate pro- and anti-inflammatory mediators (cytokines, chemokines, NO, PGEs, growth factors and superoxide species [15], which in turn, up-regulate adhesion molecules, increase permeability of the blood–brain ba…”
BackgroundSnowden, J. N., Beaver, M., Smeltzer, M. S., & Kielian, T. (2012) · Infection and Immunity · doi:10.1128/iai.00645-12 · Cited by 49
“However, in response to injury or infection, the central nervous system is capable of mounting a robust immune response, albeit deviant in some respects, from similar insults in the periphery (15, 23, 27).”
BackgroundLi, S., Marks, J. A., Eisenstadt, R., Kumasaka, K., Samadi, D., Johnson, V. E., Holena, D. N., Allen, S. R., Browne, K. D., Smith, D. H., et al. (2015) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000000697 · Cited by 49
“In particular, peripheral LEU infiltration into brain tissue with subsequent activation of resident immune cells such as microglia and astrocytes has been found to occur through an imbalance between local concentrations of proinflammatory and anti-inflammatory cytokines.(32,33) In this process, activation of circulati…”
BackgroundPenkowa, M., Cáceres, M., Borup, R., Nielsen, F. C., Poulsen, C. B., Quintana, A., Molinero, A., Carrasco, J., Florit, S., Giralt, M., et al. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21043 · Cited by 47
“In general, ROSmediated oxidative stress is responsible for secondary brain damage, including neurodegeneration and ultimately apoptotic cell death, which can be prominent after a primary neurotrauma (Mhatre et al., 2004; Lucas et al., 2006; Potashkin and Meredith, 2006).”
BackgroundPatel, J. C., Shukla, M., & Shukla, M. (2025) · Cells · doi:10.3390/cells14120918 · Cited by 48
da Cunha, A. A., Ferreira, A. G. K., & Wyse, Â. T. D. S. (2010) · Metabolic Brain Disease · doi:10.1007/s11011-010-9188-8 · Cited by 49
“TNF-α is one of the central mediators of tissue inflammation and induces synthesis of other inflammatory cytokines ( Lucas et al. 2006 ), whilst elevated IL-6 levels are closely related to an increased risk of myocardial infarction (Lindmark et al. 2001; Ridker et al. 2000a); as such, our findings that demonstrate tha…”
ResultDetermination of LC50 and sub-chronic neurotoxicity of diesel exhaust nanoparticles
Durga, M., Devasena, T., & Rajasekar, A. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.06.024 · Cited by 50
Wu, P., Hao, H., Hong, W. D., Wu, T.-R., Zhao, S., Cui, X.-P., Zhong, Y., Li, D., Xu, X., Zhao-jun, S., et al. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s176390 · Cited by 48
Kumar, A., Sood, A., & Han, S. S. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb00131d · Cited by 48
Xu, Y., Nygård, M., Kristensson, K., & Bentivoglio, M. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.09.006 · Cited by 48
“The regional and molecular heterogeneity of glial cells, and in particular of microglia, may then play a crucial role in the outcome of the inflammatory response towards neuroprotection or neurodegeneration (Carson et al., 2006; Kim et al., 2000; Lucas et al., 2006; Minghetti, 2005; Schroeter and Jander, 2005; Sriram…”
BackgroundBiber, N., Toklu, H. Z., Solakoğlu, S., Gultomruk, M., Hakan, T., Berkman, Z., & Dulger, F. (2009) · Brain Injury · doi:10.1080/02699050902926317 · Cited by 48
Khaksari, M., Abbasloo, E., Dehghan, F., Soltani, Z., & Asadikaram, G. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.05.046 · Cited by 47
Titomanlio, L., Fernández‐López, D., Manganozzi, L., Moretti, R., Vexler, Z. S., & Gressèns, P. (2015) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2015.01.016 · Cited by 47
Interferon-β attenuates lung inflammation following experimental subarachnoid hemorrhage
Cobelens, P. M., Tiebosch, I. A., Dijkhuizen, R. M., van der Meide, P. H., Zwartbol, R., Heijnen, C. J., Kesecioğlu, J., & van den Bergh, W. M. (2010) · Critical Care · doi:10.1186/cc9232 · Cited by 47
“It has been suggested that increased intracranial production of pro-inflammatory cytokines results in the release of systemic pro-inflammatory mediators, thereby promoting secondary organ injury [8].”
BackgroundChik, S. C. C., Or, T. C. T., Luo, D., Yang, C. L.-H., & Lau, A. S. Y. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/896873 · Cited by 47
“Increasing evidence shows that neurodegenerative diseases aremediated by neuroinflammation, oxidative stress, and apoptotic cell death [2, 3].”
BackgroundXiang, Y., Zhao, H., Wang, J., Zhang, L., Liu, A., & Chen, Y. (2016) · Biomedical Reports · doi:10.3892/br.2016.677 · Cited by 47
“It is characterized by activation of glial cells, influx of peripheral immune and inflammatory cells, high concentrations of reactive oxygen species (ROS) and release of proinflammatory mediators, including cytokines and adhesion molecules (11-13).”
Zhang, S., Sun, W., Liang, Z., Yin, X., Ji, Z.-R., Chen, X., Wei, M.-J., & Pei, L. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s245445 · Cited by 47
Metadata
- Authors
- Lucas, S., Rothwell, N. J., & Gibson, R. M.
- Affiliations
- University of Manchester (GB)
- HSE Science and Research Centre (GB)
- Corresponding author
- Rothwell, Nancy J
- ORCID
- Rothwell, Nancy J
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2006-01
- Volume
- 147
- Issue
- S1
- Pages
- S232-40
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1760754
- OpenAlex
- W1594425991
- Cited by
- 1,272
- References
- 41
- Citations by year
- 2026: 12 · 2025: 37 · 2024: 32 · 2023: 57 · 2022: 65 · 2021: 69 · 2020: 62 · 2019: 80 · 2018: 67 · 2017: 67 · 2016: 60 · 2015: 89 · 2014: 77 · 2013: 79 · 2012: 62
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Keywords
- neuroinflammation, central nervous system injury, immune privilege, inflammatory cytokines, prostaglandins, free radicals, complement system, chemokines, glial activation, interleukin-1, interleukin-1 receptor antagonist, stroke, traumatic brain injury, Alzheimer's disease, anti-inflammatory therapy, neurodegeneration, aging
- MeSH terms
- Acute Disease, Animals, Brain, Central Nervous System Diseases, Chronic Disease, Craniocerebral Trauma, Humans, Inflammation, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.